Sinopia Nearing Clinic with Promising Parkinson’s Drug
Eli Walsh, July 9, 2026
In The News: San Diego Business Journal Covers Sinopia’s Seed Financing and Lead Program in Parkinson’s disease
Previous
Previous
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
Next
Next